Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Receivables (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Receivables for 4 consecutive years, with $4.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 8.13% year-over-year to $4.3 billion, compared with a TTM value of $4.3 billion through Dec 2025, up 8.13%, and an annual FY2025 reading of $4.3 billion, up 8.13% over the prior year.
  • Receivables was $4.3 billion for Q4 2025 at GE HealthCare Technologies, down from $4.4 billion in the prior quarter.
  • Across five years, Receivables topped out at $4.4 billion in Q3 2025 and bottomed at $601.0 million in Q4 2022.
  • Average Receivables over 4 years is $3.2 billion, with a median of $3.9 billion recorded in 2025.
  • The sharpest move saw Receivables soared 555.41% in 2023, then plummeted 83.61% in 2024.
  • Year by year, Receivables stood at $601.0 million in 2022, then skyrocketed by 555.41% to $3.9 billion in 2023, then increased by 0.81% to $4.0 billion in 2024, then increased by 8.13% to $4.3 billion in 2025.
  • Business Quant data shows Receivables for GEHC at $4.3 billion in Q4 2025, $4.4 billion in Q3 2025, and $3.9 billion in Q2 2025.